2m 2m 2m 2m 2m 2m 2m
PTC Therapeutics (PTCT)
NASDAQ
$64.68-$0.03 (-0.04%)
Price as of Oct 09, 2026 7:30 PM EDT- $5.4BMarket Cap
- -2.31%1-Year Change
- BiotechnologyIndustry
PTC Therapeutics (PTCT)
$64.68-$0.03 (-0.04%)
PTCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $64.70 | ||
Change | +$2.14 (+3.42%) | ||
Open | $62.52 | ||
High | $64.73 | ||
Low | $62.20 | ||
Previous Close | $62.56 | ||
Volume | 1,171,187 | ||
30-Day Average Volume | 1,280,174 | ||
1-Week Change | 1.95% | ||
1-Month Change | -4.25% | ||
1-Year Change | -2.31% | ||
3-Year Change | 203.04% | ||
5-Year Change | 76.15% | ||
Fundamentals | |||
Shares Outstanding | 83.5M | ||
Total Assets | $3.3B | ||
Market Cap | $5.4B | ||
Enterprise Value | $4.9B | ||
Period: QTR TTM FY | |||
Revenue | $238.8M | ||
Net Income | $83.5M | ||
Free Cash Flow | $126.9M | ||
EBIT | $146.0M | ||
EBITDA | $161.9M | ||
Net Working Capital | $1.8B | ||
EPS | $0.92 | ||
Enterprise Value/EBITDA | 31 | ||
Enterprise Value/Revenue | 21 | ||
P/B | -33 | ||
P/E | 70 | ||
PEG | 0 | ||
Price/Free Cash Flow | 43 | ||
Price/Operating Cash Flow | 42 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue